PTAB To Review Cubicin Patents Challenged By Fresenius
The U.S. Patent Trial and Appeal Board agreed Thursday to institute inter partes reviews under the America Invents Act for two Cubist Pharmaceuticals LLC patents on the blockbuster antibiotic Cubicin at...To view the full article, register now.
Already a subscriber? Click here to view full article